(Q53670822)
Statements
1 reference
Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program. (English)
1 reference
Evan A Stein
1 reference
Donald G Vidt
1 reference
James Shepherd
1 reference
Valerie A Cain
1 reference
Deborah Anzalone
1 reference
Michael D Cressman
1 reference
3 January 2012
1 reference
221
1 reference
2
1 reference
471-477
1 reference
Identifiers
1 reference